The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pembrolizumab (Pem) for advanced non-small cell lung cancer (aNSCLC): Efficacy and safety in everyday clinical practice.
 
Doran Ksienski
Honoraria - Bristol-Myers Squibb; Merck
Research Funding - AstraZeneca
 
Elaine S. Wai
No Relationships to Disclose
 
Nicole Croteau
No Relationships to Disclose
 
Ashley Freeman
No Relationships to Disclose
 
Leathia Fiorino
No Relationships to Disclose
 
Angela Chan
Honoraria - AstraZeneca; Bristol-Myers Squibb; Merck; Novartis; Pfizer
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genomic Health; Merck; Novartis; Roche; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Pfizer
 
Georgia Samantha Geller
No Relationships to Disclose
 
Zia Poonja
Honoraria - Bristol-Myers Squibb; Merck; Roche Canada
Consulting or Advisory Role - AstraZeneca; Merck; Takeda
 
Edward Geoffrey Brooks
No Relationships to Disclose
 
Dave Fenton
No Relationships to Disclose
 
Sarah Irons
No Relationships to Disclose
 
Mary Lesperance
No Relationships to Disclose